ASCEND BY NTHRYS
Research Abroad Products

Regulomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1–12 of 200 project topics
Transcription Factor Binding Prediction SaaS Platform
Commercial platform that predicts transcription factor-DNA binding sites using machine learning models trained on ChIP-seq and ATAC-seq datasets. Enables pharma companies to identify novel drug targets by mapping regulatory landscapes in disease-relevant cell types.
Gene Regulatory Network Drug Target Analytics Click to view more details →
CRISPR Screen Analysis Tool for Regulatory Element Validation
Software tool that integrates CRISPR screening data with gene regulatory network models to validate enhancers and promoters as functional drug targets. Reduces target validation time by 60% and accelerates lead compound identification for biotech firms.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Disease-Specific Gene Regulatory Network Database Service
Commercial database and API service that provides curated, tissue-specific gene regulatory networks for cancer, cardiovascular, and neurological diseases. Monetizes through enterprise subscriptions to pharmaceutical R&D teams seeking pre-validated regulatory target maps.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Single-Cell Regulomics Data Integration and Mining Platform
Enterprise SaaS platform that integrates scRNA-seq, scATAC-seq, and spatial transcriptomics to map cell-type-specific regulatory programs and identify patient subpopulation targets. Delivers precision medicine insights that justify $50K+ annual licensing fees for clinical diagnostics companies.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Regulatory Variant Effect Prediction Tool for Drug Response
Commercial tool that predicts how non-coding genetic variants affect transcription factor binding and gene expression, correlating to drug response phenotypes. Enables pharmacogenomics companies to stratify patient populations and personalize treatment recommendations.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Network Pharmacology Platform for Target De-Risking
SaaS platform that models how candidate drug targets perturb gene regulatory networks to predict off-target effects and mechanism-based toxicity. Reduces clinical trial failures by 35% through early-stage network-based target validation.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Enhancer-Driven Gene Discovery Engine for Rare Disease
Commercial discovery tool that uses enhancer activity maps and long-range chromatin interactions to identify disease-causing genes in rare genetic disorders. Enables biotech companies to unlock undruggable gene space and develop therapies for ultra-orphan indications.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Master Regulator Identification Platform for Immunotherapy
Specialized analytics platform that identifies master transcriptional regulators controlling immune cell differentiation and exhaustion programs. Accelerates immunotherapy target discovery for oncology companies developing checkpoint inhibitors and CAR-T cell therapies.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Temporal Gene Regulatory Network Modeling for Disease Progression
Software suite that reconstructs and models time-dependent changes in gene regulatory networks across disease stages using multi-omics time-series data. Enables therapeutic companies to identify stage-specific targets and optimize intervention timing in chronic diseases.
Gene Regulatory Network Drug Target Analytics Click to view more details →
Regulatory Mutation Burden Assessment for Cancer Genomics
Commercial analytics tool that quantifies regulatory element mutations and their functional impact on cancer driver pathways using patient whole-genome sequencing. Drives revenue through licensing to oncology research centers and personalized cancer medicine platforms.
Gene Regulatory Network Drug Target Analytics Click to view more details →
TF Binding Site Prediction Engine for Drug Discovery
A SaaS platform that predicts transcription factor binding sites across genomic regions using machine learning models trained on ChIP-seq datasets. This accelerates drug target validation and reduces preclinical screening costs by 40-60% for pharmaceutical companies.
Transcription Factor Regulomics Analytics Tools Click to view more details →
Regulatory Network Mapping Platform for Precision Medicine
Enterprise software that constructs patient-specific transcription factor regulatory networks from multi-omics data to identify disease-causing perturbations. It enables personalized treatment recommendations and supports precision oncology revenue models worth $2M+ annually per healthcare system.
Transcription Factor Regulomics Analytics Tools Click to view more details →